A broader question might be to what extent are companies being forced by the unreasonable demands of this 'clunky' system to make this kind of proposal. Isn't the proposal a response to something? MSAC would be wise to consider what that something is rather than issue statements shifting blame and insulting healthcare companies.
Where does the system end if statements like this become a feature of our decision-making?
July 8, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered
May 30, 2025 - - Australian Biotech -
Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics
May 29, 2025 - - Latest News -
TGA approves new therapy for children with growth hormone deficiency
May 29, 2025 - - Latest News -
AbbVie Australia appoints Dr Carly Levetan associate medical director
May 29, 2025 - - Latest News -
For patients, it's about understanding their experience and accessing the touchpoints
May 29, 2025 - - Latest News -
Priceline Pharmacy launches annual event with national menopause project
May 28, 2025 - - Latest News -
Anne Ruston welcomes her reappointment to health and the addition of NDIS
May 28, 2025 - - Latest News